|
⚲
|
| Keyboard |
| Rizvi Qasim
✚
|
|
|---|---|
| CIK # | 0001794636 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001794636] | |
| 4 | [0001794636] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Rizvi Qasim | |
| Kiniksa Pharmaceuticals International PLC |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Kiniksa Pharmaceuticals International PLC KNSA
Class A Common Share
|
2020-12-31 | Tax withheld | 2,161 | $17.67 | 38,185 |
|
Kiniksa Pharmaceuticals International PLC KNSA
Restricted Share Unit · derivative
|
2020-12-31 | Option exercise | 7,337 | $0.00 | |
|
Kiniksa Pharmaceuticals International PLC KNSA
Class A Common Share
|
2020-12-31 | Option exercise | 7,337 | ||
|
Kiniksa Pharmaceuticals International PLC KNSA
Share Option · derivative
|
2020-09-10 | Grant | 75,000 | $0.00 | |
|
Kiniksa Pharmaceuticals International PLC KNSA
Share Option · derivative
|
2020-03-13 | Grant | 75,000 | $0.00 | |
|
Kiniksa Pharmaceuticals International PLC KNSA
Restricted Share Units · derivative
|
2019-12-12 | Grant | 7,337 | $0.00 | |
|
Kiniksa Pharmaceuticals International PLC KNSA
Class A Common Shares · derivative
|
2019-12-06 | Grant | 30,000 | $0.00 |